SAMHD1: a new insight into HIV-1 restriction in myeloid cells

Corine St Gelais1, Li Wu

  • 1Center for Retrovirus Research, Department of Veterinary Bioscience, The Ohio State University, 1900 Coffey Road, Columbus, OH 43210, USA.

Retrovirology
|July 12, 2011
PubMed

Insights

Human myeloid cells resist HIV-1 infection. Viral Vpx proteins degrade the SAMHD1 restriction factor, enabling HIV-1 entry and replication in these cells, impacting lentiviral pathogenesis.

Area of Science:

  • Virology
  • Immunology
  • Cell Biology

Background:

  • Human myeloid cells are naturally resistant to HIV-1 infection.
  • Viral Vpx proteins from HIV-2 and SIV overcome this resistance.
  • This occurs via proteasomal degradation of a cellular restriction factor.

Purpose of the Study:

  • To identify the cellular restriction factor targeted by Vpx.
  • To elucidate the mechanism of HIV-1 restriction in myeloid cells.
  • To explore the role of Vpx in lentiviral pathogenesis.

Main Methods:

  • Investigated the interaction between Vpx and cellular proteins.
  • Utilized proteasomal degradation assays.
  • Assessed HIV-1 infection levels in myeloid cells following SAMHD1 manipulation.

Main Results:

  • Identified SAMHD1 as the myeloid-cell-specific HIV-1 restriction factor.
  • Demonstrated that Vpx induces the proteasomal degradation of SAMHD1.
  • Showed that SAMHD1 degradation enhances HIV-1 infection in myeloid cells by inhibiting viral DNA synthesis.

Conclusions:

  • SAMHD1 is a key cellular factor restricting HIV-1 in myeloid cells.
  • Vpx-mediated degradation of SAMHD1 is a critical step in overcoming this restriction.
  • These findings offer insights into lentiviral pathogenesis and potential therapeutic targets.

Related Concept Videos